BPG is committed to discovery and dissemination of knowledge
Minireviews
©The Author(s) 2025.
World J Radiol. Oct 28, 2025; 17(10): 108804
Published online Oct 28, 2025. doi: 10.4329/wjr.v17.i10.108804
Figure 2
Figure 2 Residual hepatocellular carcinoma after trans-arterial chemoembolization in a 72-year-old man with hepatitis C virus-related hepatic cirrhosis. A: On unenhanced computed tomography obtained one month after trans-arterial chemoembolization the residual tumor (dotted arrow) shows no Lipiodol retention and the necrotic tumor (arrow) shows homogeneous Lipiodol retention; B: On hepatic arterial phase the residual tumor shows enhancement and the necrotic tumor shows no enhancement; C: On delayed phase the residual tumor shows wash-out.


Write to the Help Desk